RxDoctor Payments Data

Ceciliana de Andino de Jesus, MD

Urology · Mayaguez, PRNPI 1689820359

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Procept Biorobotics Corporation at 46.4% of the total. 2025 is the largest year on record at $1,133, 6.3 times the $180 reported in 2019. That places this record below the midpoint for urology clinicians in PR, where the typical reported total is $2,115.

$2,324in general payments, 2019–2025

Across 14 payments — averaging $165.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$1K
  • Teleflex LLC$366
  • Axonics, Inc.$233
  • Medtronic$150
  • E.r. Squibb & Sons, L.L.C.$125
  • Neotract Inc.$105
  • plus $265 from 4 others

What the payments were for

  • Travel & lodging$1,07946%
  • Food & beverage$1,24554%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,324 in reported general payments places this provider in the 50th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$5,628
Medicare patients
12
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron219$106,089
Estradiol152$13,104
Tolterodine Tartrate ErTolterodine Tartrate95$5,730
Mirabegron ErMirabegron13$4,611
Oxybutynin Chloride ErOxybutynin Chloride256$3,531
Tamsulosin Hcl252$2,220
Bethanechol Chloride60$1,804
Finasteride114$1,194
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst33$722
Methenamine Hippurate20$690
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$507
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim176$428
Bicalutamide16$389
Oxybutynin Chloride26$155
Levofloxacin29$143

Paid to pharmacies, not to this prescriber.

Other urology in Mayaguez

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →